ODDB.org: Open Drug Database

Swissmedic Registration	69227	Date of registration	12.02.2025
Company name	UCB-Pharma SA	Revision date
		Valid until	11.02.2030
Indication		Date of market entry
Index Therapeuticus (BSV)		Revocation Date
Index Therapeuticus (Swissmedic)	07.15.	Information for professionals	IP

Seq.-No.	Product	Description	Galenic form	ATC-classification
01	Rystiggo 280 mg/2 ml	solution injectable	Injection solution (Rozanolixizumabum 280mg / 2ml)	L04AG16	CI
02	Rystiggo 420 mg/3 ml	solution injectable	Injection solution (Rozanolixizumabum 420mg / 3ml)		CI

2026	©ywesee GmbH